Loading clinical trials...
Loading clinical trials...
Multicentric, Prospective, Double Blind, Randomized/Stratified, Placebo-controlled Pilot-study for Evaluation of Safety and Efficacy of Flupirtine add-on to Interferon-β1b on Neurodegeneration in Patients With Relapsing Remitting Multiple Sclerosis
Conditions
Interventions
Flupirtine
Placebo
Locations
4
Germany
NeuroCure Clinical Research Center, Charité Berlin
Berlin, Germany
Carl-Thiem-Clinic Cottbus
Cottbus, Germany
University of Göttingen, Department of Neurology
Göttingen, Germany
University of Ulm, Department of Neurology
Ulm, Germany
Start Date
December 1, 2007
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
March 20, 2018
NCT04047628
NCT04602390
NCT05978531
NCT04225312
NCT03536559
NCT05446285
Lead Sponsor
Charite University, Berlin, Germany
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions